Comparable Results of Subretinal Injection and Intravitreal Injection of Tissue Plasminogen Activator in the Treatment of Submacular Hemorrhage: A Meta-Analysis of Efficacy

The IVI group showed a better BCVA at 3 months, the two groups showed comparable results in the recovery of BCVA, CRT and complete hemorrhage displacement at the final visit (within 6 months).